Serveur d'exploration MERS - Checkpoint (Istex)

Index « Teeft.i » - entrée « Human plasma »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Human placental ribonuclease inhibitor < Human plasma < Human plasma fractionation  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 11.
Ident.Authors (with country if any)Title
000698 (2009) Current literature in mass spectrometry
000811 (2008) Current literature in mass spectrometry
000926 (2007) C. V. Sapan ; H. M. Reisner [États-Unis] ; R. L. Lundblad [États-Unis]Antibody therapy (IVIG): evaluation of the use of genomics and proteomics for the study of immunomodulation therapeutics
000B16 (2005) Alan D. Borthwick [Royaume-Uni]Design of translactam HCMV protease inhibitors as potent antivirals
000D91 (2001) Sarah E. Henson [États-Unis] ; Donald Smith [États-Unis] ; Susan A. Boackle [États-Unis] ; V. Michael Holers [États-Unis] ; David R. Karp [États-Unis]Generation of recombinant human C3dg tetramers for the analysis of CD21 binding and function
000F07 (2001) Christopher R. Lowe [Royaume-Uni]Combinatorial approaches to affinity chromatography
001298 (1998) Makoto Koizumi [Japon] ; Rika Koga [Japon] ; Hitoshi Hotoda [Japon] ; Toshinori Ohmine [Japon] ; Hidehiko Furukawa [Japon] ; Toshinori Agatsuma [Japon] ; Takashi Nishigaki [Japon] ; Koji Abe [Japon] ; Toshiyuki Kosaka [Japon] ; Shinya Tsutsumi [Japon] ; Junko Sone [Japon] ; Masakatsu Kaneko [Japon] ; Satoshi Kimura [Japon] ; Kaoru Shimada [Japon]Biologically active oligodeoxyribonucleotides. Part 11: The least phosphate-modification of quadruplex-forming hexadeoxyribonucleotide TGGGAG, bearing 3′- and 5′-end-modification, with anti-HIV-1 activity
001434 (1997) Włodzimierz Buczko [Pologne] ; Czesław Cierniewski [Pologne] ; Anna Kobyla Ska [Pologne] ; Maria Koziołkiewicz [Pologne] ; And Rzej Okruszek [Pologne] ; Zofia Pawłowska [Pologne] ; Elzbzieta Pluskota [Pologne] ; Wojciech J. Stec [Pologne]Modulation of plasminogen activator inhibitor type-1 biosynthesis in vitro and in vivo with oligo(nucleoside phosphorothioate)s and related constructs
001461 (1997) Makoto Koizumi [Japon] ; Rika Koga [Japon] ; Hitoshi Hotoda [Japon] ; Kenji Momota [Japon] ; Toshinori Ohmine [Japon] ; Hidehiko Furukawa [Japon] ; Toshinori Agatsuma [Japon] ; Takashi Nishigaki [Japon] ; Koji Abe [Japon] ; Toshiyuki Kosaka [Japon] ; Shinya Tsutsumi [Japon] ; Junko Sone [Japon] ; Masakatsu Kaneko [Japon] ; Satoshi Kimura [Japon] ; Kaoru Shimada [Japon]Biologically active oligodeoxyribonucleotides—IX.1 Synthesis and anti-HIV-1 activity of hexadeoxyribonucleotides, TGGGAG, bearing 3′- and 5′-end-modification
002177 (1987) Electrophoresis
002523 (1976) Michio Matsuda [Japon] ; Toshiaki Saida [Japon] ; Ryoko Hasegawa [Japon]Cryofibrinogen in the plasma of patients with skin ulcerative lesions on the legs: A complex of fibrinogen and cold insoluble globulin

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Istex/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Teeft.i -k "Human plasma" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Teeft.i  \
                -Sk "Human plasma" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    Istex
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Teeft.i
   |clé=    Human plasma
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021